John R. Burnett

6.5k total citations
164 papers, 4.6k citations indexed

About

John R. Burnett is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John R. Burnett has authored 164 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Surgery, 58 papers in Endocrinology, Diabetes and Metabolism and 48 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John R. Burnett's work include Lipoproteins and Cardiovascular Health (83 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (51 papers) and Lipid metabolism and disorders (41 papers). John R. Burnett is often cited by papers focused on Lipoproteins and Cardiovascular Health (83 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (51 papers) and Lipid metabolism and disorders (41 papers). John R. Burnett collaborates with scholars based in Australia, Canada and United States. John R. Burnett's co-authors include Amanda J. Hooper, Gerald F. Watts, Frank M. van Bockxmeer, P. Hugh R. Barrett, Damon A. Bell, Murray W. Huff, Robin Williams, Cyril Mamotte, A. David Marais and Donald Moshen Tanyanyiwa and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

John R. Burnett

158 papers receiving 4.4k citations

Peers

Countries citing papers authored by John R. Burnett

Since Specialization

Citations

This map shows the geographic impact of John R. Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Burnett more than expected).

Fields of papers citing papers by John R. Burnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Burnett. The network helps show where John R. Burnett may publish in the future.

Co-authorship network of co-authors of John R. Burnett

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Burnett. A scholar is included among the top collaborators of John R. Burnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Burnett. John R. Burnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors 2023 ·Journal of clinical lipidology ·Reika Masuda, Julien Wist, Samantha Lodge, Torben Kimhofer, Michael Hunter, Jennie Hui, John Beilby, John R. Burnett, Girish Dwivedi, Markus P. Schlaich, Sze-How Bong, Ruey Leng Loo, Elaine Holmes, Jeremy K. Nicholson, Bu B. Yeap	12
2	Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia 2023 ·Journal of clinical lipidology ·Wann Jia Loh, Jing Pang, Anindita Chakraborty, Natalie C. Ward, Dick C. Chan, Amanda J. Hooper, Damon A. Bell, John R. Burnett, Andrew C. Martin, Gerald F. Watts	5
3	A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia 2022 ·Journal of clinical lipidology ·Michael M. Page, Katrina L. Ellis, Dick C. Chan, Jing Pang, Amanda J. Hooper, Damon A. Bell, John R. Burnett, Eric K. Moses, Gerald F. Watts	3
4	Design, development and deployment of a web-based patient registry for rare genetic lipid disorders 2020 ·Pathology ·Kathryn Napier, Amanda J. Hooper, (unknown), (unknown), Damon A. Bell, Jing Pang, Gerald F. Watts, M. Bellgard, John R. Burnett	1
5	Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia 2020 ·Clinica Chimica Acta ·Michael M. Page, Katrina L. Ellis, Jing Pang, Dick C. Chan, Amanda J. Hooper, Damon A. Bell, John R. Burnett, Gerald F. Watts	11
6	Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy 2016 ·Nutrition Metabolism and Cardiovascular Diseases ·Dick C. Chan, Jing Pang, P. Hugh R. Barrett, David Sullivan, Trevor A. Mori, John R. Burnett, F. M. van Bockxmeer, Gerald F. Watts	21
7	HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export 2015 ·Circulation Research ·(unknown), Mi‐Jurng Kim, Liming Hou, Wilfried Le Goff, M. John Chapman, Miranda Van Eck, Linda K. Curtiss, John R. Burnett, Siân P. Cartland, Carmel M. Quinn, Maaike Kockx, Anatol Kontush, Kerry‐Anne Rye, Leonard Kritharides, Wendy Jessup	240
8	Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects 2014 ·Journal of the American College of Cardiology ·Gilles Lambert, Francine Petrides, Mathias Chatelais, Dirk Blom, Benjamin Choque, Fatiha Tabet, (unknown), Kerry‐Anne Rye, Amanda J. Hooper, John R. Burnett, Philip J. Barter, A. David Marais	41
9	Clinical utility gene card for: Abetalipoproteinaemia 2012 ·European Journal of Human Genetics ·John R. Burnett, Damon A. Bell, Amanda J. Hooper, Robert A. Hegele	17
10	Genetic determinants of hepatic steatosis in man 2011 ·Journal of Lipid Research ·Amanda J. Hooper, Leon A. Adams, John R. Burnett	112
11	Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway 2009 ·Journal of Biological Chemistry ·Maaike Kockx, (unknown), Mathew Traini, Katharina Gaus, Jason G. Kay, Sabine Wimmer-Kleikamp, Carles Rentero, John R. Burnett, Wilfried Le Goff, Miranda Van Eck, Jennifer L. Stow, Wendy Jessup, Leonard Kritharides	20
12	A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease 2008 ·Clinica Chimica Acta ·Amanda J. Hooper, Huy Tran, (unknown), John R. Burnett	16
13	Drug profile: Sapropterin dihydrocholoride (Kuvan/Phenoptin), an orally active synthetic form of BH4 for the treatment og phenylketonuria 2007 ·John R. Burnett	11
14	Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU 2007 ·Neuropsychology Review ·(unknown), Allison M. Fox, Michael Arthur, Michael Bynevelt, John R. Burnett	147
15	A novel non-truncating ApoB gene mutation, R463W, causes familial hypobetalipoproteinemia 2002 ·Circulation ·John R. Burnett, Jing Shan, (unknown), (unknown), Jia Yuan, Karen Tran, Zhirong Yao, RA Hegele	1
16	Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis 2001 ·Clinica Chimica Acta ·John R. Burnett, (unknown), Kevin D. Croft, Andrew J. Brown, (unknown), Samuel D Vasikaran, Eran Leitersdorf, Gerald F. Watts	24
17	Therapeutic efficiency of tirofiban in acute coronary syndromes (multiple letters) 2000 ·The Lancet ·John R. Burnett, John B. Blennerhassett, W. B. McConnell, Peter O’Leary, Samuel D Vasikaran, Christopher Heeschen, C. W. Hamm, Giuseppe Biondi‐Zoccai, Piergiuseppe Agostoni	3
18	Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol 1998 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·John R. Burnett, Lisa J. Wilcox, Dawn E. Telford, (unknown), P. Hugh R. Barrett, Murray W. Huff	25
19	3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion 1997 ·Current Opinion in Lipidology ·Murray W. Huff, John R. Burnett	91
20	Pyoderma gangrenosum involving the head and neck 1988 ·The Laryngoscope ·(unknown), Gary R. Warnock, (unknown), John R. Burnett	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact